Zero Candida Technologies, Inc. (FRA:9L2)
0.0760
+0.0095 (14.29%)
At close: Jun 26, 2026
Zero Candida Technologies Company Description
Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis.
It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring.
The company is headquartered in Vancouver, Canada.
Zero Candida Technologies, Inc.
| Country | Canada |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| CEO | Eli Ben-Haroosh |
Contact Details
Address: 666 Burrard Street Vancouver, BC V6C 3P6 Canada | |
| Website | zero-candida.com |
Stock Details
| Ticker Symbol | 9L2 |
| Exchange | Frankfurt Stock Exchange |
| Reporting Currency | EUR |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Eli Ben-Haroosh | Chief Executive Officer |
| Irene Zaiton | Chief Operating Officer |